GENNARI LUIGI | Professor page

Al Refaie, A., Baldassini, L., Mondillo, C., Ceccarelli, E., Tarquini, R., Gennari, L., et al. (2025). Adiponectin may play a crucial role in the metabolic effects of GLP-1RAs treatment in patients with Type 2 Diabetes Mellitus: a preliminary longitudinal study. ENDOCRINE, 87(3), 951-958 [10.1007/s12020-024-04085-8]. - view more
Carlino, I., Al Refaie, A., Mondillo, C., Manzana, G., Bisogno, S., Pierguidi, S., et al. (2025). Are the clinical phenotypes of systemic sclerosis determinant for osteoporosis and fragility fractures?. BMC RHEUMATOLOGY, 9(1) [10.1186/s41927-025-00462-6]. - view more
Giuliano, G., Hankache, G., Sambo, M., Cusi, M.G., Lazzerini, P.E., Gennari, L., et al. (2025). Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 44, 116-126 [10.1016/j.jgar.2025.06.006]. - view more
Al Refaie, A., Baldassini, L., Mondillo, C., Gonnelli, S., Ceccarelli, E., Tarquini, R., et al. (2025). Glucagon-like peptide-1 receptor agonists (GLP-1RAs) for the treatment of type 2 diabetes mellitus: friends or foes to bone health? a narrative review of clinical studies. ENDOCRINE, 89(1), 30-38 [10.1007/s12020-025-04253-4]. - view more
Al Refaie, A., Baldassini, L., Mondillo, C., Ceccarelli, E., Tarquini, R., Gennari, L., et al. (2024). Glucagon-like Peptide-1 Receptor Agonists and Diabetic Osteopathy: Another Positive Effect of Incretines? A 12 Months Longitudinal Study. CALCIFIED TISSUE INTERNATIONAL, 115(2), 160-168 [10.1007/s00223-024-01240-1]. - view more

All publications